Home/Filings/4/0001104659-18-010127
4//SEC Filing

Grooms Jamie Mark 4

Accession 0001104659-18-010127

CIK 0000805928other

Filed

Feb 14, 7:00 PM ET

Accepted

Feb 15, 7:56 PM ET

Size

13.9 KB

Accession

0001104659-18-010127

Insider Transaction Report

Form 4
Period: 2018-02-13
Transactions
  • Sale

    Common Stock

    2018-02-13$26.20/sh7,100$186,020202,595 total(indirect: See Footnote)
  • Sale

    Common Stock

    2018-02-13$26.22/sh3,200$83,9049,073 total(indirect: See Footnote)
  • Sale

    Common Stock

    2018-02-14$26.71/sh9,073$242,3400 total(indirect: See Footnote)
  • Sale

    Common Stock

    2018-02-15$27.11/sh43,403$1,176,655126,256 total(indirect: See Footnote)
  • Sale

    Common Stock

    2018-02-14$26.72/sh32,936$880,050169,659 total(indirect: See Footnote)
Footnotes (7)
  • [F1]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.55. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.60. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F3]These shares of common stock are held indirectly by the reporting person through the Jamie Grooms Trust, of which Mr. Grooms is a trustee.
  • [F4]These shares of common stock are held indirectly by the reporting person through the Jamie Grooms Children's Trust, of which Mr. Grooms is a trustee.
  • [F5]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.10 to $27.05. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F6]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.20 to $26.95. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F7]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.50 to $27.375. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Documents

1 file

Issuer

AxoGen, Inc.

CIK 0000805928

Entity typeother

Related Parties

1
  • filerCIK 0001530935

Filing Metadata

Form type
4
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 7:56 PM ET
Size
13.9 KB